Skip to main content

Table 3 Correlation between SF-8 health profile dimensions and PVR, BNP, and Peak VO2 at baseline

From: Medium-term health-related quality of life in patients with pulmonary arterial hypertension treated with goal-oriented sequential combination therapy based on exercise capacity

  PVR Plasma BNP Peak VO2
r P r P r P
PF −0.500 <0.001 −0.496 <0.001 0.501 <0.001
RP −0.529 <0.001 −0.513 <0.001 0.657 <0.001
BP 0.050 0.754 −0.125 0.436 0.179 0.263
GH −0.455 0.003 −0.327 0.037 0.396 0.010
VT −0.390 0.012 −0.529 <0.001 0.531 <0.001
SF −0.272 0.086 −0.349 0.025 0.427 0.005
RE −0.337 0.031 −0.428 0.005 0.494 0.001
MH −0.134 0.402 −0.213 0.181 0.211 0.186
PCS −0.427 0.005 −0.417 0.007 0.411 0.003
MCS −0.158 0.323 −0.280 0.076 0.299 0.037
  1. PVR Pulmonary vascular resistance, BNP Brain natriuretic peptide
  2. Health-related quality of life was assessed by using the Medical Outcomes Study Short Form Health Survey (SF-8), which consists of eight items, each representing one health profile dimension: PF Physical functioning; RP Role functioning – physical, BP Bodily pain, GH General health perception, VT Vitality, SF Social functioning, RE Role functioning – emotional; and MH Mental health. Physical component summary (PCS) and mental component summary (MCS) scores were compared with demographically adjusted United States norms and with historical controls